‘Guns for gold’: who is complicit in Sudan’s brutal war?
After nearly 18 months of displacement, starvation and genocidal violence, minimal attention has been paid to the bloody conflict still …
After nearly 18 months of displacement, starvation and genocidal violence, minimal attention has been paid to the bloody conflict still …
The medical device coatings industry is highly specialised, which can present a challenge when trying to recruit talent. However, US-based …
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as …
US-based external-beam theranostic oncology company, RefleXion, has announced that its radiotherapy device RefleXion X1 has been used as part of …
DeepHealth and HOPPR have entered a partnership to commercialise a medical-grade generalised foundation model – a form of generative artificial …
Tempo Therapeutics has started the first in human trial for its tissue regeneration product, TT101, in patients who have undergone …
Clinical AI company Exer AI and the Mayo Clinic are teaming up to diagnose and treat acute and chronic hand …
UltraDx Bio has secured clinical registration approval for its UD-X fully automated single-molecule array fluorescence immunoassay analyser in China. This device …
Researchers at the University of Central Florida (UCF) in the US have developed an integrated optical sensor for dopamine detection …
The US Food and Drug Administration (FDA) has issued 510(k) clearance for Think Surgical’s Tmini miniature robotic system to be …
Aptar Digital Health has partnered with Guy's and St Thomas' NHS Foundation Trust in the UK to evaluate the impact …
As the number of mpox-related deaths in the Democratic Republic of Congo (DRC) and neighbouring countries continues to climb, international …
Amid the hype of weight loss pills, Allurion is pushing ahead with its swallowable balloon – with the company reporting …
Chicago-based neuromodulation firm Turing Medical has announced that its automated end-to-end brain mapping system designed to prepare clinicians to carry …
Investors are rallying around the promise of cross-species transplantation, enabling eGenesis to close a $191m Series D financing round to …